REFERENCES
- Barzegar-Jalali M., Maleki N., Garjani A., Khandar A. A., Haji-Hosseinloo M., Jabbari R., Dastmalchi S. Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique. Drug Development and Industrial Pharmacy 2002; 28: 681–686, [INFOTRIEVE], [CSA]
- Batenhorst R. L., Bustrack J. A., Bivins B. A., Foster T. S. Comparative bioavailability of chlorpropamide tablet and suspension formulations. Clinical Pharmacy 1982; 1: 58–61, [INFOTRIEVE], [CSA]
- Costa P., Sousa Lobo J. M. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 2001; 13: 123–133, [INFOTRIEVE], [CSA], [CROSSREF]
- Dastmalchi S., Garjani A., Maleki N., Sheikhee G., Baghchevan V., Jafari-Azad P., Valizadeh H., Barzegar-Jalali M. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. Journal of Pharmacy and Pharmaceutical Sciences 2005; 8: 175–181, [INFOTRIEVE], [CSA]
- Deshpande A. V., Agrawal D. K. Increasing the dissolution rate of chlorpropamide by dispersion technique using various dispersing agents. Pharmazie 1983; 38: 539–541, [CSA]
- Deshpande A. V., Agrawal D. K. Effect of different grades of polyvinylpyrrolidone on dissolution rate of chlorpropamide and its absorption through rat stomach. Drug Development and Industrial Pharmacy 1984; 10: 1725–1736, [CSA]
- Deshpande A. V., Agrawal D. K. Bioavailability studies of chlorpropamide from its polyvinylpyrrolidone coprecipitate. Pharmazie 1985; 40: 496–497, [INFOTRIEVE], [CSA]
- Dubois J. L., Ford J. L. Similarities in the release rates of different drugs from polyethylene glycol 6000 solid dispersions. Journal of Pharmacy and Pharmacology 1985; 37: 494–495, [INFOTRIEVE], [CSA]
- Evans M., Glass R. C., Mitchard M., Munday B. M., Yates R. Bioavailability of chlorpropamide. British Journal of Clinical Pharmacology 1979; 7: 101–105, [INFOTRIEVE], [CSA]
- Ford J. L., Rubinstein M. H. The effect of composition and ageing on the dissolution rates of chlorpropamide-urea solid dispersions. 1977; 29: 688–694, [CSA]
- Fredrich H., Nada A., Bodmeier R. Solid state and dissolution rate characterization of co-graound mixtures of nifedipine and hydrophilic carriers. Drug Development and Industrial Pharmacy 2005; 31: 719–728, [CSA], [CROSSREF]
- Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics 2000; 50: 47–60, [INFOTRIEVE], [CSA], [CROSSREF]
- Levy G. Comparison of dissolution and absorption rates of different commercial aspirin tablets. Journal of Pharmaceutical Sciences 1961; 50: 388–392, [INFOTRIEVE], [CSA], [CROSSREF]
- Noyes A. A., Whitney W. R. The rates of solution of solid substances in their own solutions. Journal American Chemical Society 1897; 19: 930–934, [CSA], [CROSSREF]
- Sweetman S. C. Martindale: The complete drug reference. Pharmaceutical Press, London 2005
- Taylor T., Assinder D. F., Chasseaud L. F., Bradford P. M., Burton J. S. Plasma concentrations, bioavailability and dissolution of chlorpropamide. European Journal of Clinical Pharmacology 1977; 11: 207–212, [INFOTRIEVE], [CSA], [CROSSREF]
- Van Der Watt J. G., Parrott E. L., Devilliers M. M. A comparison of interaction and solvent deposition mixing. Drug Development and Industrial Pharmacy 1996; 22: 741–746, [CSA]
- Wagner J. G. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. Journal of Pharmaceutical Sciences 1969; 58: 1253–1257, [INFOTRIEVE], [CSA], [CROSSREF]
- Yen S. Y., Chen C. R., Lee M. T., Chen L. C. Investigation of dissolution enhancement of nifedipine by deposition on superdisintegrants. Drug Development and Industrial Pharmacy 1997; 23: 313–317, [CSA]